These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19350100)

  • 21. Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel.
    Sibbing D; von Beckerath N; Morath T; Stegherr J; Mehilli J; Sarafoff N; Braun S; Schulz S; Schömig A; Kastrati A
    Eur Heart J; 2010 May; 31(10):1205-11. PubMed ID: 20159881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patients.
    Simon N; Finzi J; Cayla G; Montalescot G; Collet JP; Hulot JS
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1059-66. PubMed ID: 26071277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel.
    Siriswangvat S; Sansanayudh N; Nathisuwan S; Panomvana D
    Circ J; 2010 Oct; 74(10):2187-92. PubMed ID: 20736505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coadministration of clopidogrel and proton pump inhibitors.
    Keller DL
    Cleve Clin J Med; 2011 May; 78(5):284; author reply 284-5. PubMed ID: 21688684
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy.
    Zuern CS; Geisler T; Lutilsky N; Winter S; Schwab M; Gawaz M
    Thromb Res; 2010 Feb; 125(2):e51-4. PubMed ID: 19781742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton pump inhibitor co-therapy with clopidogrel: is there GI benefit or cardiovascular harm?
    Laine L
    Gastroenterology; 2011 Mar; 140(3):769-72. PubMed ID: 21266209
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention.
    Mizia-Stec K; Haberka M; Mizia M; Lasota B; Kunecki M; Gieszczyk K; Chmiel A; Najda J; Kyrcz-Krzemień S; Gąsior Z
    Pharmacol Rep; 2012; 64(2):360-8. PubMed ID: 22661187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting.
    Ma B; Hang L; Chen G; Du Y
    West Indian Med J; 2013 Feb; 62(2):135-9. PubMed ID: 24564063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Thromb Res; 2011 Oct; 128(4):352-7. PubMed ID: 21621250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clopidogrel with or without omeprazole in coronary artery disease.
    Bhatt DL; Cryer BL; Contant CF; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Scirica BM; Murphy SA; Cannon CP;
    N Engl J Med; 2010 Nov; 363(20):1909-17. PubMed ID: 20925534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.
    Cuisset T; Frere C; Quilici J; Poyet R; Gaborit B; Bali L; Brissy O; Morange PE; Alessi MC; Bonnet JL
    J Am Coll Cardiol; 2009 Sep; 54(13):1149-53. PubMed ID: 19761935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction.
    Fontes-Carvalho R; Albuquerque A; Araújo C; Pimentel-Nunes P; Ribeiro VG
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):396-404. PubMed ID: 21464720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation.
    Rossini R; Capodanno D; Musumeci G; Lettieri C; Lortkipanidze N; Romano M; Nijaradze T; Tarantini G; Cicorella N; Sirbu V; Guagliumi G; Rosiello R; Valsecchi O; Gavazzi A
    Coron Artery Dis; 2011 May; 22(3):199-205. PubMed ID: 21358542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clopidogrel and PPI interaction: clinically relevant or not?
    Harrison RW; Mahaffey KW
    Curr Cardiol Rep; 2012 Feb; 14(1):49-58. PubMed ID: 22090195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin and clopidogrel resistance-a myth or reality: an update.
    Gupta S; Gupta MM
    Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
    [No Abstract]   [Full Text] [Related]  

  • 36. Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries.
    Hemetsberger R; Farhan S; Strehblow C; Sperker W; Pavo I; Petrasi Z; Hemetsberger H; Posa A; Huber K; Glogar D; Gyöngyösi M
    Coron Artery Dis; 2008 Dec; 19(8):635-43. PubMed ID: 19005299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet function analysis: at the edge of meaning.
    Oestreich JH; Smyth SS; Campbell CL
    Thromb Haemost; 2009 Feb; 101(2):217-9. PubMed ID: 19190799
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study.
    Gajos G; Rostoff P; Undas A; Piwowarska W
    J Am Coll Cardiol; 2010 Apr; 55(16):1671-8. PubMed ID: 20394870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting thrombotic events: creating a complex approach for a complex condition.
    Shantsila E; Lip GY
    Thromb Haemost; 2008 Dec; 100(6):962-4. PubMed ID: 19132217
    [No Abstract]   [Full Text] [Related]  

  • 40. Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease.
    Addad F; Chakroune T; Asma A; Abderazek F; Zohra D; Ghrissi I; Hassine M; Gamra H; Elalamy I
    Thromb Res; 2009 Feb; 123(4):640-3. PubMed ID: 18602138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.